array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(659)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(97) "Hartford Investment Management Co. Has $452,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(249) "Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)."
["url"]=>
string(134) "https://www.defenseworld.net/2024/04/08/hartford-investment-management-co-has-452000-position-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/90fd6be9-d94a-403b-9ecd-b42236ac8bbd"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-04-08"
["categories"]=>
array(4) {
[0]=>
string(9) "Valuation"
[1]=>
string(18) "General Investment"
[2]=>
string(11) "Regulations"
[3]=>
string(31) "Financial Update/Profit Warning"
}
}
[1]=>
array(7) {
["title_en"]=>
string(88) "Private Advisor Group LLC Has $234,000 Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(231) "Private Advisor Group LLC increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission."
["url"]=>
string(126) "https://www.defenseworld.net/2023/12/03/private-advisor-group-llc-has-234000-holdings-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/22e3d56b-b7d5-4b29-a3d6-33ac65de01b1"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-12-03"
["categories"]=>
array(6) {
[0]=>
string(11) "Acquisition"
[1]=>
string(11) "Regulations"
[2]=>
string(9) "Valuation"
[3]=>
string(20) "Corporate Governance"
[4]=>
string(31) "Financial Update/Profit Warning"
[5]=>
string(18) "General Investment"
}
}
[2]=>
array(7) {
["title_en"]=>
string(90) "Daiwa Securities Group Inc. Raises Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(230) "Daiwa Securities Group Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 8.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission."
["url"]=>
string(128) "http://www.defenseworld.net/2023/07/29/daiwa-securities-group-inc-raises-stock-holdings-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/43967ea1-bd68-4e85-9f5b-7522e8ecf599"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-07-29"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(18) "General Investment"
[2]=>
string(9) "Valuation"
[3]=>
string(11) "Regulations"
}
}
[3]=>
array(7) {
["title_en"]=>
string(103) "Retirement Systems of Alabama Has $3.05 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(253) "Retirement Systems of Alabama decreased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 7.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC)."
["url"]=>
string(141) "http://www.defenseworld.net/2023/07/28/retirement-systems-of-alabama-has-3-05-million-stock-holdings-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0550b9af-20f0-450a-82b6-c91678851851"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-07-28"
["categories"]=>
array(5) {
[0]=>
string(11) "Regulations"
[1]=>
string(9) "Valuation"
[2]=>
string(31) "Financial Update/Profit Warning"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(77) "Libra Wealth LLC Acquires Shares of 445 Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(299) "Libra Wealth LLC bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 445 shares of the medical research company's stock,"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-bio-sec-filing-2023-07-21/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/55b9d9b8-a0e6-4b1f-96b6-eed09e498f14"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2023-07-21"
["categories"]=>
array(6) {
[0]=>
string(11) "Acquisition"
[1]=>
string(11) "Regulations"
[2]=>
string(14) "Issuing Shares"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(24) "Stock Research & Ratings"
[5]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(105) "New York State Teachers Retirement System Reduces Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)"
["snippet_en"]=>
string(233) "New York State Teachers Retirement System lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 0.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission."
["url"]=>
string(144) "http://www.defenseworld.net/2023/07/21/new-york-state-teachers-retirement-system-reduces-stock-position-in-bio-rad-laboratories-inc-nysebio.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f549395b-c418-4643-a2f7-78cf71dd5cb9"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2023-07-21"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(9) "Valuation"
[2]=>
string(11) "Regulations"
}
}
[6]=>
array(7) {
["title_en"]=>
string(55) "BIO Stock Price, Forecast & News (Bio-Rad Laboratories)"
["snippet_en"]=>
string(173) "Researching Bio-Rad Laboratories (NYSE:BIO) stock? View BIO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat."
["url"]=>
string(43) "https://www.marketbeat.com/stocks/NYSE/BIO/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/69688266-5bcb-4eab-a8e0-f2a6fe10ebd2"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2020-04-06"
["categories"]=>
array(4) {
[0]=>
string(15) "Insider Trading"
[1]=>
string(12) "Stock Market"
[2]=>
string(11) "Regulations"
[3]=>
string(21) "Competitive Behaviour"
}
}
[7]=>
array(7) {
["title_en"]=>
string(88) "Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government"
["snippet_en"]=>
string(248) "Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government Date: Fully Settles DOJ and SEC Investigations Regarding International"
["url"]=>
string(171) "https://www.bio-rad.com/en-fr/corporate/newsroom/bio-rad-laboratories-resolves-foreign-corrupt-practices-act-matters-with-u-s-government?ID=Bio-Rad-Laboratories_1423518846"
["image_url"]=>
NULL
["source"]=>
string(11) "bio-rad.com"
["publication_date"]=>
string(10) "2014-11-03"
["categories"]=>
array(3) {
[0]=>
string(19) "Government Policies"
[1]=>
string(11) "Regulations"
[2]=>
string(10) "Misconduct"
}
}
[8]=>
array(7) {
["title_en"]=>
string(56) "SEC Charges Bio-Rad Laboratories With Bribery Violations"
["snippet_en"]=>
string(176) "The Securities and Exchange Commission charged Bio-Rad Laboratories , a clinical diagnostic and life-science research company, with violating the Foreign Corrupt Practices Act."
["url"]=>
string(88) "https://foxbusiness.com/markets/sec-charges-bio-rad-laboratories-with-bribery-violations"
["image_url"]=>
NULL
["source"]=>
string(15) "foxbusiness.com"
["publication_date"]=>
string(10) "2014-11-03"
["categories"]=>
array(4) {
[0]=>
string(7) "Bribery"
[1]=>
string(15) "Business Ethics"
[2]=>
string(10) "Misconduct"
[3]=>
string(11) "Regulations"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
659 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).
Private Advisor Group LLC increased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
Daiwa Securities Group Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 8.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
Retirement Systems of Alabama decreased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 7.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).
Libra Wealth LLC bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 445 shares of the medical research company's stock,
New York State Teachers Retirement System lowered its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 0.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government Date: Fully Settles DOJ and SEC Investigations Regarding International
The Securities and Exchange Commission charged Bio-Rad Laboratories , a clinical diagnostic and life-science research company, with violating the Foreign Corrupt Practices Act.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.